P 2 Y 12 receptor-mediated activation of spinal microglia and p 38 MAPK pathway contribute to cancer-induced bone pain

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiallodynic effects of propentofylline Elicited by interrupting spinal glial function in a rat model of bone cancer pain

  2011cited by this paper
• P2X7 receptor‐deficient mice are susceptible to bone cancer pain

  2011influential reference
• Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord

  2011cited by this paper
• Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain.

  2010influential reference
• Mode of action of P2Y12 antagonists as inhibitors of platelet function

  2010cited by this paper
• Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms.

  2010influential reference
• Involvement of nerve injury and activation of peripheral glial cells in tetanic sciatic stimulation‐induced persistent pain in rats

  2010cited by this paper
• The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.

  2009cited by this paper
• Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing

  2009cited by this paper
• Effects of chronic inflammation and morphine tolerance on the expression of phospho-ERK 1/2 and phospho-P38 in the injured tissue

  2009cited by this paper
• Activation of p38 Mitogen-activated Protein Kinase in Spinal Microglia Contributes to Incision-induced Mechanical Allodynia

  2009cited by this paper
• Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain

  2009influential reference
• P2Y12 Receptors in Spinal Microglia Are Required for Neuropathic Pain after Peripheral Nerve Injury

  2008cited by this paper
• Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain.

  2008cited by this paper
• Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury.

  2008cited by this paper
• Translational medicine: cancer pain mechanisms and management.

  2008cited by this paper
• [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].

  2008cited by this paper
• [The cellular location and significance of p38alpha/beta isoforms in the lumbar spinal cord of the bone cancer pain rats].

  2007cited by this paper
• Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus

  2007cited by this paper
• Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.

  2006cited by this paper
• Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord

  2006cited by this paper
• Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

  2006cited by this paper
• Complete Freunds adjuvant‐induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS

  2004cited by this paper
• Potential of p38 MAP kinase inhibitors in the treatment of cancer.

  2003cited by this paper
• Selective expression of Gi/o‐coupled ATP receptor P2Y12 in microglia in rat brain

  2003cited by this paper
• Excitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan‐induced behavioral hyperalgesia and spinal fos expression in rats

  2002cited by this paper
• A rat model of bone cancer pain

  2002cited by this paper
• Identification of the platelet ADP receptor targeted by antithrombotic drugs

  2001cited by this paper
• Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

  2000cited by this paper
• Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain

  1999cited by this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper

• B14 ameliorates bone cancer pain through downregulating spinal interleukin-1β via suppressing neuron JAK2/STAT3 pathway

  2019cites this paper